معرفی
Marie-France Demers is an Associate Professor at the Faculty of Pharmacy, Université Laval, and a clinical pharmacist at the Notre-Dame-des-Victoires Clinic (CNDV), where she has worked for over two decades. She is co-director of the RAPPSODIS laboratory (Person-Centered Research and Psychosis: Integrated Approach to Care) and serves as Director of the Postgraduate Professional Diploma in Specialized Pharmaceutical Care. Her work bridges clinical practice, research, and education in psychiatric pharmacy and mental health.
- Bachelor of Pharmacy, Université Laval (1992)
- Master’s in Hospital Pharmacy, Université Laval (1993)
- Graduate Training in Statistics and Epidemiology, Université Laval (1995–1997)
- Board Certified in Psychiatric Pharmacy, American College of Psychiatric and Neurologic Pharmacists (2016)
Her research focuses on improving pharmaceutical care for individuals with psychosis, particularly in early intervention and recovery-oriented models. Key areas include treatment adherence, clozapine use, social anxiety in schizophrenia, antipsychotic effectiveness, and knowledge translation. She has led and co-led multiple funded research projects, including those supported by SSHRC, FRQ-SC, and industry grants. Her work emphasizes interdisciplinary collaboration, patient-centered approaches, and real-world clinical outcomes.
The 15 most recent publications reflect a strong focus on pharmacovigilance (e.g., aripiprazole and gambling), treatment optimization (e.g., clozapine with G-CSF), diagnostic improvement (e.g., detecting social anxiety), and innovative care models (e.g., DJ’s Choices, PEP project). The articles span clinical case reports, observational studies, and intervention research, primarily in schizophrenia and early psychosis, with an emphasis on practical applications in mental health services.
- Prix Hippocrate (2015), awarded by Le Patient magazine for interdisciplinary practice at CNDV
- Poster Presentation Award, College of Family Physicians of Canada (2015)
Marie-France Demers has supervised or co-supervised six graduate students and contributed to the training of numerous pharmacy, medical, and psychology trainees. She has secured research funding from federal and provincial agencies as well as unrestricted grants from pharmaceutical sponsors. Her educational contributions include leading key pharmacotherapy courses and developing specialized postgraduate programs. She actively collaborates with psychiatrists, psychologists, social workers, and patient partners in her research and clinical initiatives.
She co-directs the RAPPSODIS laboratory, which brings together researchers, clinicians, and patients to develop and evaluate integrated care models for psychosis. The team includes pharmacists, nurses, neuropsychologists, and master’s students, working on projects such as CAP on Recovery, SeASONS, and the PEPS study. Her leadership in knowledge translation is evident in public-facing books and workshops like DJ’s Choices, designed to support families in treatment adherence.
